健康元：健康元药业集团股份有限公司2022年社会责任报告（英文版）.PDF

1、For the health For the futureProduct Quality Control Mechanism05Quality Management System Quality Risk Control Quality Culture Cultivation Supply Chain Quality Management Intellectual Property Rights Protection Responsible Marketing 242829313335The Report at a GlanceAbout JoincareGovernanceChairmans

2、 Statement01030402Group OverviewOrganisational Structure Corporate Culture Key Performance Honours 810111112CSR Strategy CSR Governance Communication on CSR Compliance Governance Carrying Forward the Party-Masses Spirit Integrity and Business Ethics Information Security14141517192022ContentsAccess t

3、o Healthcare06Focusing on R&D and Innovation Paying Attention to Rare Diseases Treatment Improving the Availability of Medicines384344Operating with Green SustainabilityTalent ManagementData List of Key Performance IndicatorsPublic Welfare and Charity08071009Environmental Management System Addressin

4、g Climate ChangeEmission Management Resource Utilisation Management66707378 Protection of Rights and Interests of Employees Talent Recruiting and RetentionOccupational Health and Safety525461Promoting Industry-based Welfare Promoting Health-based Welfare and Charity81824Joincare Pharmaceutical Group

5、 Industry Co.,Ltd.01The Report at a GlanceOverviewThe report,covering the period from 1 January 2022 to 31 December 2022,is the sixth corporate social responsibility(CSR)report issued by Joincare Pharmaceutical Group Industry Co.,Ltd.(Stock Code:600380).In view of the continuity and comparability of

6、 some data,some contents of this report may be extended or traced back to other periods where applicable.Scope of the ReportThe report covers Joincare and its wholly-owned subsidiaries and holding subsidiaries.Preparation BasisThis report is prepared mainly in accordance with the No.1 Guidelines for